Literature DB >> 22985250

Functional and histological outcome after focal traumatic brain injury is not improved in conditional EphA4 knockout mice.

Anders Hånell1, Fredrik Clausen, Anders Djupsjö, Anna Vallstedt, Kalicharan Patra, Charlotte Israelsson, Martin Larhammar, Maria Björk, Sónia Paixão, Klas Kullander, Niklas Marklund.   

Abstract

We investigated the role of the axon guidance molecule EphA4 following traumatic brain injury (TBI) in mice. Neutralization of EphA4 improved motor function and axonal regeneration following experimental spinal cord injury (SCI). We hypothesized that genetic absence of EphA4 could improve functional and histological outcome following TBI. Using qRT-PCR in wild-type (WT) mice, we evaluated the EphA4 mRNA levels following controlled cortical impact (CCI) TBI or sham injury and found it to be downregulated in the hippocampus (p<0.05) but not the cortex ipsilateral to the injury at 24 h post-injury. Next, we evaluated the behavioral and histological outcome following CCI using WT mice and Emx1-Cre-driven conditional knockout (cKO) mice. In cKO mice, EphA4 was completely absent in the hippocampus and markedly reduced in the cortical regions from embryonic day 16, which was confirmed using Western blot analysis. EphA4 cKO mice had similar learning and memory abilities at 3 weeks post-TBI compared to WT controls, although brain-injured animals performed worse than sham-injured controls (p<0.05). EphA4 cKO mice performed similarly to WT mice in the rotarod and cylinder tests of motor function up to 29 days post-injury. TBI increased cortical and hippocampal astrocytosis (GFAP immunohistochemistry, p<0.05) and hippocampal sprouting (Timm stain, p<0.05) and induced a marked loss of hemispheric tissue (p<0.05). EphA4 cKO did not alter the histological outcome. Although our results may argue against a beneficial role for EphA4 in the recovery process following TBI, further studies including post-injury pharmacological neutralization of EphA4 are needed to define the role for EphA4 following TBI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22985250     DOI: 10.1089/neu.2012.2376

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  8 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

Review 2.  Traumatic brain injury using mouse models.

Authors:  Yi Ping Zhang; Jun Cai; Lisa B E Shields; Naikui Liu; Xiao-Ming Xu; Christopher B Shields
Journal:  Transl Stroke Res       Date:  2014-02-05       Impact factor: 6.829

3.  Therapeutic effects of pharmacologically induced hypothermia against traumatic brain injury in mice.

Authors:  Jin Hwan Lee; Ling Wei; Xiaohuan Gu; Zheng Wei; Thomas A Dix; Shan Ping Yu
Journal:  J Neurotrauma       Date:  2014-07-07       Impact factor: 5.269

4.  Identification of serum microRNA signatures for diagnosis of mild traumatic brain injury in a closed head injury model.

Authors:  Anuj Sharma; Raghavendar Chandran; Erin S Barry; Manish Bhomia; Mary Anne Hutchison; Nagaraja S Balakathiresan; Neil E Grunberg; Radha K Maheshwari
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

Review 5.  The Controlled Cortical Impact Model: Applications, Considerations for Researchers, and Future Directions.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Front Neurol       Date:  2016-08-17       Impact factor: 4.003

6.  Conditional Deletion of EphA4 on Cx3cr1-Expressing Microglia Fails to Influence Histopathological Outcome and Blood Brain Barrier Disruption Following Brain Injury.

Authors:  Eman Soliman; Jatia Mills; Jing Ju; Alexandra M Kaloss; Erwin Kristobal Gudenschwager Basso; Nathalie Groot; Colin Kelly; Elizabeth A Kowalski; Mohamed Elhassanny; Michael Chen; Xia Wang; Michelle H Theus
Journal:  Front Mol Neurosci       Date:  2021-09-24       Impact factor: 6.261

7.  NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands.

Authors:  Carlo Baggio; Anna Kulinich; Cassandra N Dennys; Rochelle Rodrigo; Kathrin Meyer; Iryna Ethell; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2021-07-22       Impact factor: 8.039

8.  Peripheral loss of EphA4 ameliorates TBI-induced neuroinflammation and tissue damage.

Authors:  Elizabeth A Kowalski; Jiang Chen; Amanda Hazy; Lauren E Fritsch; Erwin Kristobal Gudenschwager-Basso; Michael Chen; Xia Wang; Yun Qian; Mingjun Zhou; Matthew Byerly; Alicia M Pickrell; John B Matson; Irving Coy Allen; Michelle H Theus
Journal:  J Neuroinflammation       Date:  2019-11-11       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.